Publicaciones en las que colabora con Pablo Ramirez Romero (103)

2024

  1. Cell-specific Extracellular Vesicles and Their miRNA Cargo Released Into the Organ Preservation Solution During Cold Ischemia Storage as Biomarkers for Liver Transplant Outcomes

    Transplantation

  2. Cell-specific Extracellular Vesicles and Their miRNA Cargo Released Into the Organ Preservation Solution During Cold Ischemia Storage as Biomarkers for Liver Transplant Outcomes

    Transplantation

  3. Operational tolerance research in liver transplantation: a bibliometric analysis using a new web resource

    Frontiers in Research Metrics and Analytics, Vol. 9

2023

  1. Endothelial cell activation mediated by cold ischemia-released mitochondria is partially inhibited by defibrotide and impacts on early allograft function following liver transplantation

    Biomedicine and Pharmacotherapy, Vol. 167

  2. Postoperative negative-pressure incision therapy after liver transplant (PONILITRANS study): A randomized controlled trial

    Surgery (United States), Vol. 173, Núm. 4, pp. 1072-1078

  3. Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis

    Cancers, Vol. 15, Núm. 7

2022

  1. Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation

    International Journal of Molecular Sciences, Vol. 23, Núm. 22

2021

  1. A high concentration of TGF-β correlates with opportunistic infection in liver and kidney transplantation

    Human Immunology, Vol. 82, Núm. 6, pp. 414-421

  2. Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis

    Obesity Surgery, Vol. 31, Núm. 3, pp. 1214-1222

  3. Biomarkers of Early Liver Graft Damage in Circulatory Death and Brain Death Donors: A Propensity Score Matching Analysis

    Transplantation Proceedings, Vol. 53, Núm. 9, pp. 2659-2662

  4. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

    Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155

  5. Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients

    Clinical and Experimental Immunology, Vol. 203, Núm. 2, pp. 315-328

  6. Proteomics in Liver Transplantation: A Systematic Review

    Frontiers in Immunology, Vol. 12

2020

  1. Attitude Toward Related Living Donation Among Patients on Waiting List for Liver Transplantation

    Transplantation Proceedings, Vol. 52, Núm. 2, pp. 462-464

  2. Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again

    American Journal of Transplantation, Vol. 20, Núm. 1, pp. 204-212

  3. Impact of Hepatic Artery Thrombosis on the Success of a Liver Transplant Because of Hepatocellular Carcinoma

    Transplantation Proceedings, Vol. 52, Núm. 2, pp. 559-561

  4. Influence of preformed antibodies in liver transplantation

    Journal of Clinical Medicine, Vol. 9, Núm. 3

  5. Predisposition Toward Living Liver Donation Is Low Among Relatives of Patients on the Waiting List for Transplantation in Spain

    Transplantation Proceedings, Vol. 52, Núm. 2, pp. 476-479

  6. Resilience Related to Quality of Life Perceived in Elderly Patients With Orthotopic Liver Transplant for More Than 10 Years

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1511-1513

  7. Response to “Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again”

    American Journal of Transplantation